Dexcom appoints Rimma Driscoll to Board of Directors; fills audit/tech committee seats

DEXCOM INC

Rimma Driscoll elected to Board effective August 24, 2023.
She replaces Nicholas Augustinos on Audit and Technology Committees.
Ms. Driscoll is EVP at Zoetis, leading global strategy, commercial and business development.
She received initial RSU grant valued at $500,000 vesting over 3 years.
Board determined she qualifies as independent under Nasdaq and SEC rules.

item 5.02 item 8.01 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Rimma Driscoll

Director

DXCM · DEXCOM INC

Effective: 2023-08-24
Filed: August 28, 2023, 7:59 PM ET

Effective on August 24, 2023, the Board of Directors (the “Board”) of DexCom, Inc. (“Dexcom”) elected Rimma Driscoll to fill a vacancy on the Board and to replace Nicholas Augustinos as a member of the Audit Committee of the Board and the Technology Committee of the Board.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Rimma Driscoll was elected as Director at DEXCOM INC.

Action: elected
Role: Director

Exact text from the filing

Effective on August 24, 2023, the Board of Directors (the “Board”) of DexCom, Inc. (“Dexcom”) elected Rimma Driscoll to fill a vacancy on the Board and to replace Nicholas Augustinos as a member of the Audit Committee of the Board and the Technology Committee of the Board.

View on SEC.gov

DEXCOM INC filing history →

Source: SEC EDGAR

accession 0001093557-23-000191

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.